Additionally, the genetic dimension comes into play, with microarray analysis revealing differential expression of KCNH2, SCN5A, and SNTA1—genes associated with long QT syndrome—when cells are treated with ribociclib. This evidence concerns the gene SCN5A and Prolonged QT interval.